10,712.00p+206.00 (+1.96%)12 Aug 2022, 18:45
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.

Astrazeneca PLC Market & Company News

12.08.2022 08:13AZNTOP NEWS: AstraZeneca's Enhertu approved for more patients in USAlliance
12.08.2022 07:00AZNEnhertu approved in US for HER2-mutant NSCLCRNS
11.08.2022 07:00AZNAcquisition of TeneoTwo completedRNS
09.08.2022 13:27AZNAstraZeneca reports promising results for antibody drug conjugate Alliance
08.08.2022 11:32HCM, AZNUPDATE: Hutchmed, AstraZeneca move lung cancer drug to phase 3 trialAlliance
08.08.2022 08:59AZNTOP NEWS: AstraZeneca's Enhertu approved for more patients in USAlliance
08.08.2022 07:10AZNEnhertu approved in the US for HER2-low mBCRNS
05.08.2022 13:38AZNIN BRIEF: AstraZeneca's Calquence tablet formulation approved in USAlliance
04.08.2022 09:58BIRG, BAG, JETLONDON BROKER RATINGS: Goldman likes NatWest; Barclays cuts Just EatAlliance
04.08.2022 09:41AZNAstraZeneca, Merck's Lynparza approved in EU for breast cancer Alliance
04.08.2022 07:00AZNLynparza approved in EU for early breast cancerRNS
01.08.2022 17:00AZNDirector/PDMR ShareholdingRNS
01.08.2022 15:05AZNDirector/PDMR ShareholdingRNS
01.08.2022 15:00AZNTotal Voting RightsRNS
01.08.2022 09:46JET2, SNR, KGHLONDON BROKER RATINGS: HSBC cuts Jet2; JPMorgan lifts Anglo AmericanAlliance
29.07.2022 12:32BOO, ASC, IAGLONDON MARKET MIDDAY: Apple, Amazon and NatWest cheer investorsAlliance
29.07.2022 09:30IAG, BARC, ITRKLONDON MARKET OPEN: Stocks up as market prices in less Fed tighteningAlliance
29.07.2022 09:11AZNTOP NEWS: AstraZeneca lifts sales guidance; promotes Demare to chairAlliance
29.07.2022 08:27GLEN, BOO, ASCLONDON BRIEFING: AstraZeneca ups payout and guidance; taps new chairAlliance
29.07.2022 07:01AZNChair successionRNS
29.07.2022 07:00AZNHalf-year ReportRNS
25.07.2022 12:25AZN, 7DIG, HLNLONDON MARKET MIDDAY: Higher start to busy week for earnings, US FedAlliance
25.07.2022 09:32AZNTOP NEWS: AstraZeneca wins two recommendations, one priority reviewAlliance
25.07.2022 07:10AZNTezspire recommended for EU approval in asthmaRNS
25.07.2022 07:05AZNUltomiris recommended for EU approval for gMGRNS
25.07.2022 07:00AZNEnhertu granted Priority Review for HER2-low mBCRNS
22.07.2022 16:09YOU, WCW, STANUK earnings, trading statements calendar - next 7 daysAlliance
19.07.2022 09:22AZNTOP NEWS: AstraZeneca breast cancer drug wins approval in EUAlliance
19.07.2022 07:00AZNEnhertu approved in EU for HER2-positive mBCRNS
13.07.2022 09:35AZN, HCMIN BRIEF: Hutchmed presents solid results from lung cancer studyAlliance
12.07.2022 09:35ESP, THS, DEVOLONDON BROKER RATINGS: RBC, Goldman, Jefferies review property sharesAlliance
07.07.2022 10:30HTG, IPX, GBGLONDON BROKER RATINGS: Berenberg cuts Rio Tinto and BofA lowers AntoAlliance
05.07.2022 07:00AZNAstraZeneca to acquire TeneoTwo and T cell engagerRNS
01.07.2022 15:00AZNTotal Voting RightsRNS
01.07.2022 09:08HBR, AZN, OXBLONDON MARKET OPEN: Lacklustre start to second half on recession fearAlliance
01.07.2022 08:31OXB, AZNOxford BioMedica signs new Covid-19 vaccine deal with AstraZenecaAlliance
30.06.2022 10:17AZNTOP NEWS: AstraZeneca sees positive data for lung cancer drug ImfinziAlliance
30.06.2022 07:00AZNImfinzi improved pCR in resectable lung cancerRNS
29.06.2022 12:25AZN, NFXIN BRIEF: Nuformix shares rise as progresses with cancer programmeAlliance
27.06.2022 09:18BIFF, SHEL, AZNLONDON MARKET OPEN: Europe joins equities rally; pound improvesAlliance
27.06.2022 09:04AZNTOP NEWS: AstraZeneca wins EU recommendation for breast cancer drugsAlliance
27.06.2022 07:05AZNEnhertu recommended for breast cancer EU approvalRNS
27.06.2022 07:00AZNLynparza recommended in EU for early breast cancerRNS
23.06.2022 15:59AZNAstraZeneca's Wilson disease treatment shows promise in phase 3 trialsAlliance
21.06.2022 22:01AZNMerck & Co, Astra drug improves survival in prostate cancer sufferersAlliance
21.06.2022 08:32AZNAstraZeneca's polyneuropathy candidate Eplontersen sees positive dataAlliance
21.06.2022 07:00AZNEplontersen Ph III trial met co-primary endpointsRNS
14.06.2022 12:17XSG, GOG, BWYLONDON MARKET MIDDAY: Full percentage point US rate hike fear voicedAlliance
14.06.2022 09:33BPM, CMCX, TLWLONDON BROKER RATINGS: Berenberg and HSBC upgrade Wizz AirAlliance
14.06.2022 08:17AZN, CBG, WIZZLONDON BRIEFING: BoE dilemma as basic UK pay falls 2.2% in real termsAlliance
13.06.2022 13:52AZNDaiichi Sankyo doses first person in breast cancer treatment trialAlliance
09.06.2022 10:34AZNAstraZeneca's Calquence shows longer survival rate for leukaemia formAlliance
08.06.2022 09:48AZNAstraZeneca antibody reduces risk of severe Covid-19 or deathAlliance
06.06.2022 17:12EVE, EZJ, WIZZLONDON MARKET CLOSE: Stocks green; sterling strong ahead of UK PM voteAlliance
06.06.2022 12:32AFN, AZN, RIOLONDON MARKET MIDDAY: Pound up as UK PM expected to survive Tory pollAlliance
06.06.2022 09:57AZNAstraZeneca sees breast cancer drug Enhertu improve median overall survival Alliance
06.06.2022 07:00AZNEnhertu efficacy results in HER2-low breast cancerRNS
01.06.2022 15:00AZNBlock listing Interim ReviewRNS
01.06.2022 15:00AZNTotal Voting RightsRNS
23.05.2022 08:58AZNTOP NEWS: AstraZeneca Covid vaccine wins booster jab approval in EUAlliance
23.05.2022 08:24AZN, KGF, BRBYREPEAT: LONDON BRIEFING: Kingfisher plans capital returnAlliance
23.05.2022 08:18AZN, KGF, BRBYLONDON BRIEFING: Kingfisher plans capital return despite cost pressureAlliance
20.05.2022 16:00AZNDirector/PDMR ShareholdingRNS
18.05.2022 12:28TUI, PFD, EXPNLONDON MARKET MIDDAY: Pound lower, stocks mixed after"peak" inflationAlliance
18.05.2022 10:34MADE, ITM, SBRELONDON BROKER RATINGS: Kepler cuts Astra to hold; RBC raises ReckittAlliance
17.05.2022 09:12AZNTOP NEWS: AstraZeneca wins license to make and sell Covid antibodiesAlliance
16.05.2022 14:34GSK, AZNAstraZeneca's PTO27 shows positive results in people with asthmaAlliance
16.05.2022 12:16AZN, NSCINetScientific shares jump after "impressive" results of Covid-19 testAlliance
09.05.2022 13:00AZNAppointment of joint corporate brokersRNS
06.05.2022 16:00AZNDirector/PDMR ShareholdingRNS
05.05.2022 09:39AZNAstraZeneca's Enhertu approved in US, results for Farxiga, UltomirisAlliance
05.05.2022 07:10AZNEnhertu approved in US for 2L HER2+ breast cancerRNS
05.05.2022 07:05AZNFarxiga HFpEF Phase III trial met primary endpointRNS
05.05.2022 07:00AZNUltomiris NMOSD Ph. III trial met primary endpointRNS
04.05.2022 09:19AZNAstraZeneca's Imfinzi granted US priority review for bile duct cancerAlliance
Showing 1 to 75 of 288